Skip to main content

Clinical Trials › NCT06796504

RecruitingNA

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Sponsored by SetPoint Medical Corporation

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
60
Target enrollment
4
U.S. states
Mar 2026
Start date
Sep 2030
Expected completion

Interventions / Treatments

Procedure/Surgery: Implant ProcedureDisease-Modifying Therapies (DMTs)Device: Active stimulationDevice: Non-active stimulation

Conditions studied

Relapsing Remitting Multiple Sclerosis

Where this trial is running (4 sites)

Georgia1 site
Atlanta
Minnesota1 site
Plymouth
Seattle
Morgantown

Participating MS centers on MS Buddy (3)

MS centers in Georgia

Compare treatment centers near a trial site by center type, providers and trials.

View Georgia centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play